These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8803893)

  • 1. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
    Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
    Cook AD; Rowley MJ; Wines BD; Mackay IR
    J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S; Vanhecke D; Trendelenburg M
    Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M
    Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice.
    Hogarth MB; Norsworthy PJ; Allen PJ; Trinder PK; Loos M; Morley BJ; Walport MJ; Davies KA
    Clin Exp Immunol; 1996 May; 104(2):241-6. PubMed ID: 8625515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
    Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B
    J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
    Agnello V; Mitamura T
    Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.
    Kleer JS; Rabatscher PA; Weiss J; Leonardi J; Vogt SB; Kieninger-Gräfitsch A; Chizzolini C; Huynh-Do U; Ribi C; Trendelenburg M
    Front Immunol; 2021; 12():761395. PubMed ID: 35087514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits.
    Uwatoko S; Gauthier VJ; Mannik M
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):268-73. PubMed ID: 1914260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus.
    Siegert CE; Daha MR; Lobatto S; van der Voort EA; Breedveld FC
    Immunol Res; 1992; 11(2):91-7. PubMed ID: 1431425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
    Antes U; Heinz HP; Hartung K; Loos M
    Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus.
    Seelen MA; Trouw LA; van der Hoorn JW; Fallaux-van den Houten FC; Huizinga TW; Daha MR; Roos A
    Clin Exp Immunol; 2003 Nov; 134(2):335-43. PubMed ID: 14616796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus.
    Ravelli A; Wisnieski JJ; Ramenghi B; Ballardini G; Zonta L; Martini A
    Clin Exp Rheumatol; 1997; 15(2):215-9. PubMed ID: 9196878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
    Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F
    J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.